Product image of Pantoprazol Ratiopharm (Pantoprazole) supplied by GNH India

Pantoprazol Ratiopharm

Active Ingredient:
Pantoprazole
Origin:
EU

Pantoprazol Ratiopharm (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.
GNH India supplies Pantoprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazol Ratiopharm is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions:

  • Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining.
  • Erosive oesophagitis: heals erosions caused by chronic acid exposure.
  • Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid production.
  • Helicobacter pylori eradication regimens (as adjunct): improves eradication success when combined with antibiotics.

How It Works

  • Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly lowers gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Side Effects

Pantoprazol Ratiopharm may cause a range of adverse reactions. Most are mild and resolve after continued therapy.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhoea: loose stools without blood.
  • Nausea: occasional upset stomach.
  • Abdominal pain: cramping or discomfort.
  • Flatulence: increased gas production.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
  • Clostridioides difficile infection: persistent watery diarrhoea.
  • Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
  • Bone fractures: increased risk with long‑term use.
  • Liver enzyme elevation: signs of hepatic stress.
  • Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Precautions & Warnings

When prescribing Pantoprazol Ratiopharm, clinicians should consider several safety aspects:

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Monitor magnesium: prolonged therapy can lower serum magnesium.
  • Evaluate bone health: long‑term use is linked to fracture risk.
  • Review concomitant medications: potential for altered absorption of drugs requiring gastric acidity.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light.

Avoid Interactions

Pantoprazol Ratiopharm can affect the pharmacokinetics of several co‑administered medicines. Interaction categories are:

Major Interactions (Avoid)

  • Ketoconazole or itraconazole: reduced antifungal absorption.
  • Atazanavir: markedly decreased antiviral exposure.
  • Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR.
  • Digoxin: slight increase in serum levels.
  • Methotrexate (high dose): reduced renal clearance.
  • Iron supplements: decreased iron absorption.

Frequently Asked Questions

Pantoprazol Ratiopharm contains pantoprazole, a proton pump inhibitor that reduces stomach acid. It is commonly prescribed for gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease, Zollinger‑Ellison syndrome and as part of Helicobacter pylori eradication regimens.

Pantoprazole selectively and irreversibly inhibits the gastric H+/K+‑ATPase (proton pump) on parietal cells, blocking the final step of acid secretion. This lowers gastric acidity, allowing damaged mucosa to heal and reducing symptoms such as heartburn.

The specific dose and treatment duration are determined by the prescribing clinician based on the patient’s condition, severity and response. Dosage information is provided on the prescription label and should be followed exactly as instructed.

Pantoprazole is classified as pregnancy category B in the EU, indicating no evidence of risk in animal studies but limited human data. It should be used only if clearly needed after a risk‑benefit assessment, and breastfeeding mothers should consult their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazole offers a similar acid‑suppression profile to other PPIs such as omeprazole or esomeprazole, but it has a lower potential for drug‑enzyme interactions, making it a preferred option when patients are on multiple medications that rely on CYP2C19 metabolism.

Store Pantoprazol Ratiopharm tablets at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, heat and direct sunlight to maintain potency.

The medication is supplied as oral tablets that should be swallowed whole with water. It is usually taken before a meal, most often in the morning, unless the prescriber advises a different schedule.

Serious but rare risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels, bone fractures with long‑term use, liver enzyme elevations and acute interstitial nephritis. Patients should report any unusual symptoms promptly.

Individuals with known hypersensitivity to pantoprazole or other proton pump inhibitors should avoid the product. Caution is also advised for patients with severe liver disease, those taking clopidogrel, and anyone with a history of low magnesium or bone disorders unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT